Wanglin Jiang

2.4k total citations
72 papers, 2.0k citations indexed

About

Wanglin Jiang is a scholar working on Molecular Biology, Complementary and alternative medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wanglin Jiang has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Complementary and alternative medicine and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wanglin Jiang's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Advanced Glycation End Products research (12 papers) and Traditional Chinese Medicine Analysis (11 papers). Wanglin Jiang is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Advanced Glycation End Products research (12 papers) and Traditional Chinese Medicine Analysis (11 papers). Wanglin Jiang collaborates with scholars based in China and South Korea. Wanglin Jiang's co-authors include Jingwei Tian, Fenghua Fu, Haibo Zhu, Shuping Zhang, Jian Hou, Zechun Kang, Changjun Lv, Jingwei Tian, Yong Xu and Guiwu Qu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Neuroscience.

In The Last Decade

Wanglin Jiang

71 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanglin Jiang China 28 927 331 300 246 238 72 2.0k
Chunhua Ma China 28 1.2k 1.3× 268 0.8× 209 0.7× 339 1.4× 168 0.7× 56 2.3k
Sai Wang Seto Hong Kong 28 953 1.0× 470 1.4× 273 0.9× 300 1.2× 341 1.4× 85 2.6k
Dongmei Wang China 26 816 0.9× 231 0.7× 204 0.7× 138 0.6× 210 0.9× 124 2.4k
Hanan S. El‐Abhar Egypt 31 901 1.0× 564 1.7× 227 0.8× 389 1.6× 268 1.1× 104 2.8k
Kee-Ching Jeng Taiwan 26 696 0.8× 245 0.7× 525 1.8× 195 0.8× 295 1.2× 60 2.1k
Lingpeng Zhu China 27 1.4k 1.5× 234 0.7× 164 0.5× 328 1.3× 225 0.9× 46 2.5k
Jianqiang Yu China 29 1.4k 1.5× 180 0.5× 427 1.4× 214 0.9× 132 0.6× 126 2.9k
Li Yu China 25 986 1.1× 549 1.7× 199 0.7× 293 1.2× 368 1.5× 123 2.2k
Bin Lü China 28 757 0.8× 263 0.8× 213 0.7× 297 1.2× 204 0.9× 66 1.8k

Countries citing papers authored by Wanglin Jiang

Since Specialization
Citations

This map shows the geographic impact of Wanglin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanglin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanglin Jiang more than expected).

Fields of papers citing papers by Wanglin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanglin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanglin Jiang. The network helps show where Wanglin Jiang may publish in the future.

Co-authorship network of co-authors of Wanglin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Wanglin Jiang. A scholar is included among the top collaborators of Wanglin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanglin Jiang. Wanglin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Guanghua, et al.. (2025). Filgotinib Improves Experimental Pulmonary Fibrosis by Modulating JAK1/STAT3/SOCS3/IL‐17A Signalling. Basic & Clinical Pharmacology & Toxicology. 136(4). e70012–e70012.
2.
Liang, Ye, Chunmei Li, Haibo Zhu, et al.. (2024). Synthesis and evaluation of neuroactive steroids with novel pharmacophore at C-21 let identify a compound with advantageous PK profile and higher EC50 and Emax as PAM on GABAA receptor. European Journal of Medicinal Chemistry. 276. 116602–116602. 3 indexed citations
3.
Ye, Liang, Chunmei Li, Wanglin Jiang, et al.. (2023). Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist. Frontiers in Pharmacology. 14. 1218380–1218380. 2 indexed citations
4.
Liu, Bin, Chunmei Li, Wanglin Jiang, et al.. (2023). Reproductive and developmental toxicity assessments of LPM3480392, a novel mu opioid receptor biased agonist in rats. Reproductive Toxicology. 119. 108403–108403. 2 indexed citations
5.
Jiang, Wanglin, et al.. (2023). Paritaprevir ameliorates experimental acute lung injury in vitro and in vivo. Archives of Pharmacal Research. 46(6). 564–572. 6 indexed citations
6.
Yang, Yifei, Chunmei Li, Wenyan Wang, et al.. (2021). Synthesis, biological, and structural explorations of a series of μ-opioid receptor (MOR) agonists with high G protein signaling bias. European Journal of Medicinal Chemistry. 228. 113986–113986. 21 indexed citations
7.
Ji, Yunxia, Guanghua Zhang, Haibo Zhu, Defang Li, & Wanglin Jiang. (2017). Indinavir Plus Methylprednisolone Ameliorates Experimental Acute Lung Injury In Vitro and In Vivo. Shock. 49(2). 196–204. 11 indexed citations
8.
9.
Zhang, Guanghua, et al.. (2016). Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo. Phytomedicine. 23(4). 350–358. 27 indexed citations
10.
Jiang, Wanglin, Yong Xu, Shuping Zhang, Jian Hou, & Haibo Zhu. (2011). Effect of Rosmarinic Acid on Experimental Diabetic Nephropathy. Basic & Clinical Pharmacology & Toxicology. 110(4). 390–395. 27 indexed citations
11.
Xu, Yong, Wanglin Jiang, Shuping Zhang, Haibo Zhu, & Jian Hou. (2011). Protocatechuic Aldehyde Protects against Experimental Sepsis In Vitro and In Vivo. Basic & Clinical Pharmacology & Toxicology. 110(4). 384–389. 27 indexed citations
12.
Jiang, Wanglin, Shuping Zhang, Haibo Zhu, & Jian Hou. (2011). Cardioprotection of Asperosaponin X on experimental myocardial ischemia injury. International Journal of Cardiology. 155(3). 430–436. 20 indexed citations
13.
Jiang, Wanglin, Jingwei Tian, Fenghua Fu, Haibo Zhu, & Jian Hou. (2010). Neuroprotective efficacy and therapeutic window of Forsythoside B: In a rat model of cerebral ischemia and reperfusion injury. European Journal of Pharmacology. 640(1-3). 75–81. 33 indexed citations
14.
15.
Jiang, Wanglin, et al.. (2009). Cornin ameliorates cerebral infarction in rats by antioxidant action and stabilization of mitochondrial function. Phytotherapy Research. 24(4). 547–552. 36 indexed citations
16.
Li, Chunmei, Zhifeng Liu, Jingwei Tian, et al.. (2009). Protective roles of Asperosaponin VI, a triterpene saponin isolated from Dipsacus asper Wall on acute myocardial infarction in rats. European Journal of Pharmacology. 627(1-3). 235–241. 44 indexed citations
17.
Jiang, Wanglin, et al.. (2009). In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis. Phytomedicine. 17(3-4). 282–288. 88 indexed citations
18.
Jiang, Wanglin, et al.. (2009). Paeoniflorin Inhibits Systemic Inflammation and Improves Survival in Experimental Sepsis. Basic & Clinical Pharmacology & Toxicology. 105(1). 64–71. 57 indexed citations
19.
Jiang, Wanglin, Xiguang Chen, Guiwu Qu, et al.. (2009). ROSMARINIC ACID PROTECTS AGAINST EXPERIMENTAL SEPSIS BY INHIBITING PROINFLAMMATORY FACTOR RELEASE AND AMELIORATING HEMODYNAMICS. Shock. 32(6). 608–613. 51 indexed citations
20.
Tian, Jingwei, Fenghua Fu, Meiyu Geng, et al.. (2004). Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neuroscience Letters. 374(2). 92–97. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunhua Ma Breakdown of academic impact, for papers by Sai Wang Seto Breakdown of academic impact, for papers by Dongmei Wang Breakdown of academic impact, for papers by Hanan S. El‐Abhar Breakdown of academic impact, for papers by Kee-Ching Jeng Breakdown of academic impact, for papers by Lingpeng Zhu Breakdown of academic impact, for papers by Jianqiang Yu Breakdown of academic impact, for papers by Li Yu Breakdown of academic impact, for papers by Bin Lü
Rankless by CCL
2026